Neurocrine Biosciences (NBIX) Receivables - Net (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Receivables - Net of $887.0 million for Q2 2026, up 48.9% year-over-year from $595.7 million in Q2 2025, and up 15.48% on a QoQ basis from $768.1 million in Q1 2026.
Neurocrine Biosciences (NBIX) Receivables - Net (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Receivables - Net for 17 years, with the latest figure at $887.0 million in Q2 2026.
- Receivables - Net for Q2 2026 came in at $887.0 million, up 48.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $887.0 million (up 48.9% YoY), and the FY2025 annual result was $686.8 million, up 43.35% from the prior year.
- Receivables - Net climbed to $887.0 million in Q2 2026, from $768.1 million in the prior quarter.
- Over five years, Receivables - Net peaked at $887.0 million in Q2 2026 and troughed at $263.5 million in Q1 2022.
- A 5-year average of $493.9 million and a median of $459.4 million in 2024 frame the typical range for Receivables - Net.
- The widest annual swing landed in 2022, when Receivables - Net jumped 88.68%; it then gained 9.06% in 2024.
- A 5-year view of Receivables - Net shows it stood at $350.0 million in 2022, then grew by 25.51% to $439.3 million in 2023, then increased by 9.06% to $479.1 million in 2024, then jumped by 43.35% to $686.8 million in 2025, then increased by 29.15% to $887.0 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $887.0 million in Q2 2026, $768.1 million in Q1 2026, and $686.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 887.00 Mn |
| Jun 30, 2026 | 887.00 Mn |
| Mar 31, 2026 | 768.10 Mn |
| Mar 31, 2026 | 768.10 Mn |
| Dec 31, 2025 | 686.80 Mn |
| Dec 31, 2025 | 686.80 Mn |
| Sep 30, 2025 | 728.00 Mn |
| Sep 30, 2025 | 728.00 Mn |
| Jun 30, 2025 | 595.70 Mn |
| Jun 30, 2025 | 595.70 Mn |
| Mar 31, 2025 | 516.00 Mn |
| Mar 31, 2025 | 516.00 Mn |
| Dec 31, 2024 | 479.10 Mn |
| Dec 31, 2024 | 479.10 Mn |
| Sep 30, 2024 | 481.10 Mn |
| Sep 30, 2024 | 481.10 Mn |
| Jun 30, 2024 | 468.20 Mn |
| Jun 30, 2024 | 468.20 Mn |
| Mar 31, 2024 | 450.70 Mn |
| Mar 31, 2024 | 450.70 Mn |